Conference Overview

The Pharma Pricing & Market Access Innovation Summit – MENA Edition returns to Dubai on 17–18 November 2027, bringing together senior pharmaceutical executives, policymakers, healthcare authorities, payers, and industry experts to explore the evolving landscape of pharmaceutical pricing, market access, and healthcare innovation across the Middle East and North Africa.

Originally planned for December 2026, the summit has been rescheduled to November 2027 in light of the current geopolitical situation in the region. This decision reflects our commitment to providing a safe, accessible, and productive environment for all participants, while allowing sufficient time to bring together a strong international delegation.

As healthcare systems across the MENA region continue to evolve, governments and industry stakeholders face growing challenges in balancing pharmaceutical innovation, affordability, equitable patient access, and healthcare sustainability. The summit will provide a platform for exchanging insights, sharing practical experiences, and examining the policies and strategies shaping the future of market access.

Over two days, participants will engage in expert-led presentations, interactive panel discussions, and high-level networking opportunities covering key developments in pharmaceutical pricing reforms, innovative reimbursement models, health technology assessment (HTA), value-based healthcare, regulatory developments, and market access strategies across the GCC and wider MENA region.

Designed as an intimate, high-level gathering, the summit will encourage meaningful discussions, practical knowledge sharing, and valuable connections among senior decision-makers from pharmaceutical companies, government agencies, healthcare institutions, and industry organisations.

We look forward to welcoming the regional and international pharmaceutical community to Dubai in November 2027 for two days of insightful discussions, strategic networking, and collaboration aimed at improving access to innovative medicines across the MENA region.

Further programme updates, speaker announcements, and participation opportunities will be shared in the coming months.